Precision System Science

Basic Information

Stock Code
7707
Industry
Precision Instruments
Category Detail
Commercial & Industrial Machinery
Prefecture
Chiba Prefecture
Establishment Year
July 1985
Listing Year
February 2001
Official Website
https://www.pss.co.jp/
TSE Information
TSE Information
Yahoo! Finance
Yahoo! Finance
Other Companies
Interspace, VBreak, Amazia, Medorex, Delta-Fly Pharma, Second Sight Analytica, Toami, Jiban Net Holdings, Fuji Copian, W Tokyo

Overview

Precision System Science is a precision instrument manufacturer founded in 1985 and based in Matsudo City, Chiba Prefecture. It specializes in the development and sales of automated equipment for in vitro diagnostics and physicochemical instruments, operating both domestically and internationally.

Current Situation

Precision System Science, in the early 2020s, centers on DNA extraction devices as its mainstay while developing in vitro diagnostic-related equipment. It maintains stable performance with consolidated sales of approximately 3.9 billion yen and standalone sales of 3.5 billion yen. Automatic PCR devices for novel coronavirus testing have been adopted in multiple overseas countries, demonstrating high technological capability and reliability. Headquartered in Matsudo City, Chiba Prefecture, it focuses on research and development while advancing the commercialization of equipment for genetic testing and protein testing. In the market, it leverages proprietary technologies to pioneer niche markets in the in vitro diagnostics sector within precision instruments. It promotes sustainable product design and environmentally considerate initiatives, fulfilling its corporate social responsibility. Moving forward, it will strategically strengthen global expansion and expand its bio-related equipment product lineup to achieve sustainable growth. By introducing the latest technologies and maintaining a high-quality management system, it actively pursues new market development.

Trivia

Interesting Facts

  • Initially specialized in processing and installation of physicochemical instruments
  • Fully automated PCR testing device gained overseas track record ahead of domestic adoption
  • Highly evaluated by domestic and international research institutions in genetic testing
  • Rare precision instrument manufacturer that competes with majors through technology despite small scale
  • Company name PSS is abbreviation for Precision System Science
  • Pioneering bio-related instrument company headquartered in Matsudo City, Chiba Prefecture
  • Proprietary liquid handling devices adopted in many research institutions
  • Contributes to labor-saving and efficiency in testing operations through full automation
  • Shuji Tajima deeply involved in management as major shareholder
  • Improved international recognition through overseas adoption of automated PCR devices
  • Focuses on software development for in vitro diagnostics
  • Actively conducts joint research with universities and public institutions
  • Pioneers niche markets by meeting diverse customer needs
  • Approximately 100 employees enabling tight-knit organization management
  • Transitioned from JASDAQ to Tokyo Stock Exchange Growth Market

Hidden Connections

  • Received a letter of appreciation from the French Ambassador to Japan for novel coronavirus testing device
  • Deep connections in the BIO-related precision instrument industry through affiliates and competitors
  • Closely involved in the development of Japan's bio research field
  • Frequently adopted as standard equipment in universities and government research institutes
  • Forms industry community through collaboration with competitors in technology development
  • Products utilized as core devices in pharmaceutical companies' R&D
  • Contributes to forming regional bio cluster through strengthened ties with Matsudo City
  • Continues annual product exhibitions at research institution trade shows

Future Outlook

Growth Drivers

  • Increasing demand for instruments due to advancement in biomedicine
  • Ongoing international infectious disease countermeasures demand
  • Technological progress supporting automation and labor-saving
  • Expansion of genetic analysis and in vitro diagnostics markets
  • Strengthened sales in overseas markets
  • New bio-related product development
  • Diversification through entry into environmental testing
  • Integration of AI technology into testing devices
  • Accelerated joint development with research institutions
  • Growing demand for sustainable products
  • Product dissemination promoted by regulatory easing
  • Increasing medical equipment demand in aging society

Strategic Goals

  • Overseas sales ratio exceeding 50%
  • Expansion of genetic testing device lineup
  • Full product rollout of AI analysis software
  • Become industry leader in environmentally considerate products
  • Establish long-term partnerships with research institutions
  • Achieve annual sales of 10 billion yen
  • Advanced sustainability metrics
  • Strengthen community ties and expand CSR activities
  • 20% improvement in new customer acquisition rate
  • Complete overseas product certifications

Business Segments

In Vitro Diagnostic Equipment Development and Manufacturing

Overview
Develops, customizes, and manufactures advanced genetic testing and in vitro diagnostic equipment for universities and medical institutions.
Competitiveness
High testing efficiency and reliability due to high-precision, automated dedicated instruments.
Customers
  • University research institutions
  • Hospital laboratories
  • Pharmaceutical companies
  • Biotechnology companies
  • In vitro diagnostic reagent manufacturers
  • Public research facilities
  • Government agencies
  • Corporate labs
  • International research institutions
  • Environmental analysis centers
Products
  • Automated DNA extraction device
  • Automated PCR testing device
  • Protein analysis instrument
  • DNA analysis device
  • Biochip analysis system
  • Liquid handling robot
  • Real-time PCR device
  • Clinical testing sample preparation system
  • Gene amplification device
  • In vitro diagnostic reagent analysis instrument

Physicochemical Instrument Services and Support

Overview
Provides total support from installation, transportation, repair, and maintenance of physicochemical instruments to enhance customer satisfaction.
Competitiveness
Comprehensive after-sales service network and technical expertise.
Customers
  • Research institutions
  • Medical institutions
  • Universities
  • Corporate labs
  • Manufacturing companies
  • Environmental analysis facilities
  • Educational institutions
  • Government offices
  • Analysis centers
  • Pharmaceutical development companies
Products
  • Instrument installation services
  • Maintenance
  • Repair services
  • Transportation and setup
  • Consulting
  • Training
  • Technical support
  • Customization
  • Leasing services
  • Instrument calibration

Bio-related Instrument Sales

Overview
Handles a wide range of bio-related research and testing instruments, conducting sales operations domestically and internationally.
Competitiveness
Capable of serving highly specialized customers through product development backed by advanced technology.
Customers
  • Biotech companies
  • Pharmaceutical companies
  • Medical institutions
  • Research facilities
  • Lab equipment distributors
  • Environmental analysis organizations
  • Educational institutions
  • Clinical testing facilities
  • Public research institutes
  • Overseas partners
Products
  • DNA analysis instruments
  • PCR devices
  • Protein testing devices
  • Automation devices
  • Experimental instruments
  • Research software
  • Analytical consumables
  • Biological sample processing devices
  • Reagent storage devices
  • Testing robots

Custom Instrument Development

Overview
Undertakes design, prototyping, and manufacturing of custom physicochemical instruments tailored to customer needs.
Competitiveness
Flexible customization capabilities and high technological development prowess.
Customers
  • Pharmaceutical companies
  • Precision machinery manufacturers
  • Medical equipment manufacturers
  • Research institutions
  • Venture companies
Products
  • Custom testing devices
  • Automation lines
  • Prototype development
  • Software-integrated instruments

Overseas Market Expansion

Overview
Sells and supports products, including novel coronavirus testing devices, in major overseas markets.
Competitiveness
Product strength compliant with international standards and proven track record in overseas expansion.
Customers
  • Overseas medical institutions
  • Global research institutions
  • Local distributors
  • Overseas pharmaceutical companies
  • International health organizations
Products
  • Fully automated PCR device
  • Genetic testing device
  • Bioanalysis instruments
  • Local maintenance services

Competitive Advantage

Strengths

  • High-precision genetic testing device development technology
  • High testing efficiency through full automation
  • Specialization focused on in vitro diagnostics
  • Diverse sales channels and overseas expansion capabilities
  • Comprehensive after-sales service system
  • Close collaboration with biomedicine researchers
  • Global adoption record for COVID testing devices
  • High technological development capability despite small scale
  • Flexibility for custom orders
  • Accumulated expertise in precision instrument manufacturing
  • Active investment in research and development
  • Solid financial foundation
  • Long-term industry experience
  • High customer satisfaction
  • Stable capital base

Competitive Advantages

  • Market-leading share in automated DNA extraction devices
  • Novel coronavirus PCR testing device adopted in several overseas countries
  • Custom instrument development capabilities tailored to customer needs
  • Provision of high-function biochip analysis systems
  • Comprehensive product support for research institutions
  • Rapid product development and delivery system
  • Trusted relationships with government and public institutions
  • High product quality ensured through precision processing
  • Diverse lineup of testing devices
  • Promotion of overseas market certifications
  • Ownership of proprietary technology patents
  • Flexible manufacturing for small lots
  • On-site support by specialized technicians
  • High cost-performance
  • Brand strength in the in vitro diagnostics market

Threats

  • Increasing domestic and international competitors
  • Rapid technological advancements leading to obsolescence
  • Temporary decline in COVID-related demand
  • Increased burdens from stricter regulations and certifications
  • Export risks due to international situation fluctuations
  • Potential rise in raw material prices
  • Challenges in talent acquisition and technology succession
  • Patent infringement risks
  • Intensified market competition from new entrants
  • Cybersecurity risks
  • Supply chain disruptions due to geopolitical risks
  • Exchange rate instability

Innovations

2020: Development and Overseas Expansion of Automated PCR Testing Device

Overview
Developed a fully automated PCR testing device for novel coronavirus and introduced it in multiple overseas countries.
Impact
Contributes to faster and more reliable infectious disease diagnostics.

2021: Improvement of High-Sensitivity Protein Testing Device

Overview
Enhanced sensitivity and operational efficiency of protein testing devices, expanding clinical applications.
Impact
Contributes to expanded utilization in the medical field.

2022: Development of Sample Preparation Device for Next-Generation Sequencers

Overview
Launched a device that automates sample preparation for NGS analysis, significantly improving analysis speed.
Impact
Effective in enhancing work efficiency and accuracy in research institutions.

2023: Launch of AI-Equipped PCR Testing Data Analysis Software

Overview
Developed software incorporating AI technology for test data analysis to improve diagnostic accuracy and speed.
Impact
Contributes to reducing burdens in medical settings.

2024: Launch of Automated Specimen Processing Device for Environmental Testing Market

Overview
Developed and began marketing a pretreatment device specialized for water quality and soil testing.
Impact
Promotes efficiency in environmental monitoring.

Sustainability

  • Promoting energy-efficient products
  • Expanding use of recycled materials to reduce environmental impact
  • Strengthening waste recycling systems
  • Participating in local environmental protection activities
  • Introducing sustainable procurement standards
  • Implementing in-house environmental education programs
  • Setting greenhouse gas emission reduction targets
  • Pursuing environmental impact reduction in technology development
  • Implementing energy-saving and water-saving measures in offices
  • Promoting paperless operations through digitalization
  • Increasing production of recycled products
  • Conducting environmental audits of supply chains